News
Traditionally, individuals asked health questions of their primary health care provider. Confidence in that provider as a ...
Glenmark’s progress with a cancer treatment shows the potential of Indian pharma to move from generics to drug discovery.
Discover Grok 4, the AI model redefining advanced reasoning and problem-solving. Explore its potential, challenges, and ...
Below are the most-read DIGITIMES Asia stories from July 7 to July 13, 2025. This week's top three highlights include China’s ...
Mivi co-founder Midhula Devabhaktuni explains how the India-made Mivi AI Buds are ushering in a new era of conversational ...
9hon MSN
A new Stanford study reveals risks in AI therapy chatbots, which shows they may stigmatise users and give unsafe responses in mental health support.
The much-maligned 1995 cyberpunk film envisioned a world of tech addiction, brain implants, and AI companions—ideas that feel eerily relevant in today's world.
1h
Zacks Investment Research on MSNC3.ai vs. Palantir: Which Enterprise AI Stock Should You Pick Now?C3.ai, Inc. AI and Palantir Technologies Inc. PLTR are the two major players in the enterprise AI space. Both companies take a distinct approach to serving government agencies and large corporations.
Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX) (Salarius or the Company) announces that on July 10, 2025 the Company received notification from The Nasdaq Stock Market LLC (Nasdaq) of an additional ...
Synchron, a top Neuralink competitor, rarely lets journalists visit its New York headquarters. What I saw there reveals the ...
Tasked with bringing back advertising to a platform whose owner had told brands who did not spend with them to “go f--- ...
Earlier this year, when The Browser Company was looking for a cloud provider to power the artificial intelligence features in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results